• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » DrugDev launches CRO Preferred Partner Program

DrugDev launches CRO Preferred Partner Program

June 28, 2016
CenterWatch Staff

For years, DrugDev technology has been used directly by leading pharmaceutical companies to improve how their clinical trials are run. In order to advance collaboration and standardization that drive benefits throughout the industry and enable companies to do more trials, the company has launched its CRO Preferred Partner program alongside Charter Member INC Research.

When sponsors work with a Preferred Partner such as INC, they have the confidence that their selected CRO is a trustworthy expert with real-world experience using DrugDev’s SaaS tools to supplement or enhance the value of their provided services.

As a Charter Member of the program, INC Research was the first CRO to standardize on the DrugDev Golden Number, the unique identifier that powers the TransCelerate Investigator Registry and Investigator Databank. The DrugDev Golden Number is used to match and master data from disparate sources (including INC's internal experience and DrugDev’s Investigator Network) to enable superior evidence-based decisions related to study planning and site identification. This means that when sponsors partner with INC, they are leveraging the same mastered profiles for more than 500,000 global site staff and facility providers.

INC also offers sponsors use of the new DrugDev patient engagement solution, which enables sites to send reminders, documents and notifications to patients via SMS, and provides patients with a comfortable online home for all their study information—using an intuitive interface on a desktop computer or mobile app.

“As an innovation leader, INC Research is committed to investing in solutions that enable us to deliver better and more efficient services for our pharmaceutical customers,” said Jonathan Shough, chief information officer at INC Research. “We applaud industry-wide collaborative efforts and are proud to be integrated with the DrugDev Golden Number, and to provide our sponsors with direct access to the latest patient engagement solutions.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing